ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	33/224	191/7206	2.86193409364e-16
ko05164	Influenza A	30/224	167/7206	2.42328260114e-15
ko04621	NOD-like receptor signaling pathway	29/224	157/7206	3.41154085727e-15
ko05340	Primary immunodeficiency	14/224	30/7206	4.91793842711e-14
ko05162	Measles	24/224	120/7206	1.53079071831e-13
ko05168	Herpes simplex infection	29/224	182/7206	1.88368521652e-13
ko05140	Leishmaniasis	18/224	75/7206	7.39051519009e-12
ko04380	Osteoclast differentiation	23/224	134/7206	1.44738271009e-11
ko05152	Tuberculosis	27/224	187/7206	1.51077676901e-11
ko05145	Toxoplasmosis	22/224	126/7206	2.90031146716e-11
ko04064	NF-kappa B signaling pathway	19/224	96/7206	7.18517232664e-11
ko04612	Antigen processing and presentation	17/224	77/7206	1.20948297991e-10
ko04620	Toll-like receptor signaling pathway	19/224	100/7206	1.51650517389e-10
ko05320	Autoimmune thyroid disease	11/224	29/7206	4.33683036258e-10
ko05330	Allograft rejection	10/224	24/7206	9.24181609105e-10
ko04217	Necroptosis	24/224	178/7206	9.35580211832e-10
ko05321	Inflammatory bowel disease (IBD)	14/224	56/7206	9.57089344324e-10
ko04659	Th17 cell differentiation	18/224	106/7206	3.16938211816e-09
ko04660	T cell receptor signaling pathway	19/224	124/7206	6.76365741763e-09
ko05332	Graft-versus-host disease	8/224	18/7206	2.57617124283e-08
ko04658	Th1 and Th2 cell differentiation	16/224	96/7206	3.24222089743e-08
ko04650	Natural killer cell mediated cytotoxicity	16/224	97/7206	3.77677386697e-08
ko05133	Pertussis	15/224	87/7206	5.52912659167e-08
ko05161	Hepatitis B	21/224	173/7206	7.30019845117e-08
ko05150	Staphylococcus aureus infection	10/224	36/7206	8.62710599689e-08
ko04672	Intestinal immune network for IgA production	10/224	37/7206	1.15036902757e-07
ko04062	Chemokine signaling pathway	22/224	201/7206	2.26716267107e-07
ko05323	Rheumatoid arthritis	14/224	89/7206	5.05896606619e-07
ko04630	Jak-STAT signaling pathway	17/224	132/7206	5.79222526153e-07
ko05142	Chagas disease (American trypanosomiasis)	16/224	130/7206	2.32365336211e-06
ko04940	Type I diabetes mellitus	8/224	32/7206	4.24734540013e-06
ko05144	Malaria	9/224	45/7206	7.71144543974e-06
ko04145	Phagosome	17/224	162/7206	1.00967924099e-05
ko04210	Apoptosis	18/224	180/7206	1.08233337719e-05
ko04622	RIG-I-like receptor signaling pathway	10/224	62/7206	1.79573467148e-05
ko04668	TNF signaling pathway	14/224	120/7206	1.88667516149e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	18/224	191/7206	2.44665025994e-05
ko04623	Cytosolic DNA-sensing pathway	8/224	41/7206	3.03002034677e-05
ko05160	Hepatitis C	15/224	153/7206	7.5274003095e-05
ko05310	Asthma	5/224	17/7206	0.00012650180759
ko04640	Hematopoietic cell lineage	9/224	64/7206	0.000143416355441
ko03050	Proteasome	8/224	54/7206	0.000232987854358
ko05416	Viral myocarditis	8/224	55/7206	0.000265459521677
ko04662	B cell receptor signaling pathway	10/224	88/7206	0.000372111390569
ko04514	Cell adhesion molecules (CAMs)	12/224	130/7206	0.000686120374019
ko05166	HTLV-I infection	20/224	292/7206	0.000798372564923
ko04080	Neuroactive ligand-receptor interaction	3/224	423/7206	0.00125622541878
ko05131	Shigellosis	8/224	82/7206	0.00379078833056
ko05169	Epstein-Barr virus infection	14/224	206/7206	0.00616230837857
ko05034	Alcoholism	1/224	238/7206	0.00719991400137
ko04610	Complement and coagulation cascades	7/224	79/7206	0.0111019065221
ko04666	Fc gamma R-mediated phagocytosis	9/224	122/7206	0.0134607801159
ko05016	Huntington's disease	1/224	215/7206	0.0151969402775
ko05143	African trypanosomiasis	4/224	32/7206	0.0165152710226
ko05134	Legionellosis	6/224	74/7206	0.0270074859797
ko04670	Leukocyte transendothelial migration	10/224	151/7206	0.0270581327975
ko04664	Fc epsilon RI signaling pathway	6/224	77/7206	0.0320407891746
ko05132	Salmonella infection	7/224	98/7206	0.0324362321999
ko05146	Amoebiasis	7/224	99/7206	0.0340192563101
ko04510	Focal adhesion	2/224	240/7206	0.0353714474503
ko05224	Breast cancer	1/224	174/7206	0.0452902665641
ko04310	Wnt signaling pathway	1/224	181/7206	0.0465409220308